[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.13.1″]
Chemotherapy is used depending on the stages and the success of the surgery, as adjuvant therapy to eliminate possible malignant cells that have survived the operation.
The number of treatment cycles that the ovarian cancer patient will receive will depend on the stage of their disease in which they are. In this type of cancer chemotherapy can be administered in a vein (intravenous or IV) or in the womb. Recently they have incorporated to the chemotherapy treatment an antianglogenic therapy with a monoclonal antibody against VEGF that significantly improves the prognosis of ovarian cancer.
In patients treated for ovarian cancer it is very important to detect recurrences early, therefore, periodic reviews should be done, which will usually be every three months during the first two years, and later every six months. These reviews may include:
- Physical and pelvic exam.
- Analytical: hematology, biochemistry and tumor markers (Ca 125).
- Imaging tests: ultrasound, computed tomography (CT), positron emission tomography (PET) or resonance.
Learn more about your health and well-being at Pharmamedic.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
